Positron Emission Tomography
The Positron Emission Tomography (PET) group is dedicated to providing the highest quality of nuclear imaging research.
The Division of Bioimagining Sciences at the Yale School of Medicine emphasizes work in the areas of Magnetic Resonance Imaging (MRI) physics, Magnetic Resonance Spectroscopy (MRS), Positron Emission Tomography (PET) and the image analysis strategies associate with these techniques at the organ and tissue levels of scale.
Key projects range over a variety of methodology development topics and applications of developments to a number of biomedical problems. Examples include the study of cortical epilepsy in the human brain, focused on the study of biochemical changes in the brain due to epilepsy using MRS; the study of the alteration of brain cognition due to epilepsy using functional MRI (fMRI); and the development of image processing strategies that are used to perform the intricate image-guided brain surgeries that can help these patients become fully seizure-free. Work in this and other areas is typically published in more specialized journals in each of these subfields, with some work making it to more general, higher impact journals often after the methodology has been applied and tested in a particular area.
The Positron Emission Tomography (PET) group is dedicated to providing the highest quality of nuclear imaging research.
Research in the Magnetic Resonance Imaging Group is focused on technical advances in imaging.
The Yale MRS group are pioneers in many of the applications of MRS to the study of metabolism in vivo.
The aim of CMITT is to develop, apply and disseminate cutting-edge imaging technologies that take advantage of the game-changing capabilities afforded by simultaneous PET/MR.
Opportunities for diverse prospective candidates pursuing training in neuroimaging sciences.
A Program for Innovative PET Radioligand Development and Application - a translational toolbox for treatments for Mental Health
A center of innovation and excellence in the field of biomedical imaging, driving transformative biomedical advancements in both basic science and clinical applications.
An interdisciplinary research service that provides state-of-the-art MR imaging for acquisition, methodology, and data analysis. The core is equipped with five whole-body MRI scanners, including three Siemens 3T Prisma systems, a 3T Vida, and a Bruker 4T, plus two preclinical magnets (9.4T and 11.7T). With expert staff and custom-built equipment, the core supports hardware development, pulse sequence strategies, and research-focused data storage and analysis.
An FDA-registered radiotracer manufacturing and imaging facility supporting over 1,000 human and 300 small animal scans annually. The core is equipped with a GE PETtrace cyclotron, radiochemistry lab, and eight PET scanners – a United Imaging NeuroEXPLORER and Siemens Vision, mCT, HRRT, three Focus 220 and one Inveon. It supports both human and preclinical studies, enabling advanced PET research even for investigators without technical expertise.